Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

An Open-Label, Sequential-Design Drug Interaction Study of the Effects of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults

Jan de Jong, PhD, Peter Hellemans, MD, James Jiao, PhD, Juthamas Sukbuntherng, PhD, Daniele Ouellet, PhD

Blood (2016) 128 (22): 1588.

https://doi.org/10.1182/blood.V128.22.1588.1588

Published: 2016

Journal Articles

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Krishna Gundabolu, MD, Brian Trevarrow, BA, Pharm.D., BCPS, Scott A Koepsell, MD, PhD, FCAP

Blood (2015) 126 (23): 4668.

https://doi.org/10.1182/blood.V126.23.4668.4668

Published: 2015

Journal Articles

The Relative Bioavailability, Food Effect and Drug Interaction With Omeprazole Of Momelotinib Tablet Formulation

Yan Xin, PhD, Lixin Shao, MD MS, Wei Deng, PhD, Amanda Shaffer, Pharm D, Dimitrios Stefanidis, PhD, Jeffrey Hemenway, PhD, Xiaoming Li, PhD, Susie Jun, MD, PhD, Srini Ramanathan, PhD

Blood (2013) 122 (21): 5239.

https://doi.org/10.1182/blood.V122.21.5239.5239

Published: 2013

Journal Articles

Weekly Combination Chemotherapy with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for Newly Diagnosed Patients with Advanced Cardiac Disease Due to Systemic AL Amyloidosis

Furha I. Cossor, MD, Adam Boruchov, MD, Michael Danso, MD, Michael Edward Lee, Ayan Patel, MD, Eric Winer, MD, Rodney Falk, MD, Raymond L. Comenzo, MD

Blood (2011) 118 (21): 5139.

https://doi.org/10.1182/blood.V118.21.5139.5139

Published: 2011

Journal Articles

Final Results of a Multicenter Phase II Trial Assessing the Activity and Efficacy of Helicobacter Pylori -Eradicating Antibiotic Therapy As Exclusive Treatment for Patients with Stage I-II1 Diffuse Large B-Cell Lymphoma of the Stomach (the HGL-1 Trial)

Silvia Govi, MD, Caterina Patti, MD, Markus Raderer, MD, Alessandro Andriani, MD, Daniele Caracciolo, MD, Anna Guidetti, MD, Fiorella Ilariucci, MD, Stefano Luminari, MD, Antonino Mulè, MD, Edi Viale, MD, Paolo Giorgio Arcidiacono, MD, Maurilio Ponzoni, MD, Andrés J.M. Ferreri, MD

Blood (2011) 118 (21): 958.

https://doi.org/10.1182/blood.V118.21.958.958

Published: 2011

Journal Articles

Markedly Reduced Overall Survival of CYP2C19 2/2 Homozygotes After Myeloablative Hematopoietic Stem Cell Transplantation

Stacy E Melanson, MD, PhD, Kristen Stevenson, MS, Haesook T Kim, PhD, Joseph H. Antin, MD, Vincent T Ho, MD, Jerome Ritz, MD, Robert J Soiffer, MD, Michael Court, BVSc, PhD, Frank Kuo, MD, PhD, Janina Longtine, MD, Petr Jarolim, MD, PhD

Blood (2010) 116 (21): 520.

https://doi.org/10.1182/blood.V116.21.520.520

Published: 2010

Journal Articles

Dasatinib (Versus Imatinib) In Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Analysis of Safety and Efficacy by Use of Baseline Medications In the DASISION Trial

Francois Guilhot, Hagop Kantarjian, MD, Neil P. Shah, Andreas Hochhaus, M. Brigid Bradley-Garelik, David Dejardin, Jorge E. Cortes, MD

Blood (2010) 116 (21): 2295.

https://doi.org/10.1182/blood.V116.21.2295.2295

Published: 2010

Journal Articles

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

Giovanni Palladini, MD, PhD, Paola Russo, MD, Paolo Milani, MD, Andrea Foli, MD, Letizia Zenone Bragotti, MD, Laura Obici, MD, Francesca Lavatelli, MD, Silvia Brugnatelli, MD, Vittorio Perfetti, MD, PhD, Rosangela Invernizzi, MD, Giampaolo Merlini, MD

Blood (2010) 116 (21): 3062.

https://doi.org/10.1182/blood.V116.21.3062.3062

Published: 2010

Journal Articles

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Letizia Zenone Bragotti, Andrea Foli, Francesco Musca, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini

Blood (2009) 114 (22): 2863.

https://doi.org/10.1182/blood.V114.22.2863.2863

Published: 2009

Journal Articles

Management of Chronic Myelogenous Leukemia Using Therapeutic Drug Monitoring of Imatinib: The French Experience of a Centralized Laboratory

Mathieu Molimard, Stephane Bouchet, Gabriel Etienne, Laurence Legros, Delphine Rea, Francoise Huguet, Karine Titier, Nicholas Moore, Josy Reiffers, Coralie Belanger, Francois-Xavier Mahon

Blood (2008) 112 (11): 3222.

https://doi.org/10.1182/blood.V112.11.3222.3222

Published: 2008

Journal Articles

Long Term Outcome of Gastric MALT Lymphoma Patients Treated with Anti-Helicobacter (Antibiotic and Proton-Pump Inhibitor) Regimens.

Claudio Chini, MD, Graziella Pinotti, MD, Anastasios Stathis, MD, Ilaria Proserpio, MD, Francesco Bertoni, MD, Franco Cavalli, MD, Emanuele Zucca, MD

Blood (2007) 110 (11): 2583.

https://doi.org/10.1182/blood.V110.11.2583.2583

Published: 2007

Journal Articles

The Effect of the Interaction between Proton Pump Inhibitors (PPI) and Tyrosine Kinase Inhibitors (Imatinib, Nilotinib and Dasatinib).

Piera La Cava, PhD, Annalisa Chiarenza, MD, Daniele Tibullo, PhD, Cesarina Giallongo, PhD, Alessandra Romano, MD, Fabio Stagno, MD, Giuseppe A. Palumbo, MD, Francesco Di Raimondo, MD

Blood (2007) 110 (11): 2957.

https://doi.org/10.1182/blood.V110.11.2957.2957

Published: 2007

Journal Articles

Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients with Immune Thrombocytopenic Purpura (ITP).

Fabrizio Fabris, MD, Emanuele Allemand, MD, Raffaella Scandellari, MD, Silvia Vettore, PhD, Maria Luigia Randi, MD, Guido Luzzatto, MD

Blood (2005) 106 (11): 3996.

https://doi.org/10.1182/blood.V106.11.3996.3996

Published: 2005

Journal Articles

Successful Treatment of Intractable Gastrointestinal Hemorrhage with Low Dose of Recombinant FVIIa (Novoseven ® ) in Pediatric Patient without Coagulation Deficiencies.

Ji Yoon Kim, Kun Soo Lee, Soon Hak Kwon, Byung Ho Choe, Sang Kyun Sohn

Blood (2004) 104 (11): 3972.

https://doi.org/10.1182/blood.V104.11.3972.3972

Published: 2004

NARROW

An Open-Label, Sequential-Design Drug Interaction Study of the Effects of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

The Relative Bioavailability, Food Effect and Drug Interaction With Omeprazole Of Momelotinib Tablet Formulation

Weekly Combination Chemotherapy with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for Newly Diagnosed Patients with Advanced Cardiac Disease Due to Systemic AL Amyloidosis

Final Results of a Multicenter Phase II Trial Assessing the Activity and Efficacy of Helicobacter Pylori -Eradicating Antibiotic Therapy As Exclusive Treatment for Patients with Stage I-II1 Diffuse Large B-Cell Lymphoma of the Stomach (the HGL-1 Trial)

Markedly Reduced Overall Survival of CYP2C19 2/2 Homozygotes After Myeloablative Hematopoietic Stem Cell Transplantation

Dasatinib (Versus Imatinib) In Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Analysis of Safety and Efficacy by Use of Baseline Medications In the DASISION Trial

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Management of Chronic Myelogenous Leukemia Using Therapeutic Drug Monitoring of Imatinib: The French Experience of a Centralized Laboratory

Long Term Outcome of Gastric MALT Lymphoma Patients Treated with Anti-Helicobacter (Antibiotic and Proton-Pump Inhibitor) Regimens.

The Effect of the Interaction between Proton Pump Inhibitors (PPI) and Tyrosine Kinase Inhibitors (Imatinib, Nilotinib and Dasatinib).

Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients with Immune Thrombocytopenic Purpura (ITP).

Successful Treatment of Intractable Gastrointestinal Hemorrhage with Low Dose of Recombinant FVIIa (Novoseven ® ) in Pediatric Patient without Coagulation Deficiencies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only